Home
ELDN
ELDN News

Latest Eledon Pharmaceuticals Inc. (ELDN) News on November 22, 2024

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions

Simply Wall St.

8 days ago

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

GlobeNewswire

9 days ago

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

GlobeNewswire

15 days ago

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

24 days ago

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

GlobeNewswire

24 days ago

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

GlobeNewswire

2 months ago

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

GlobeNewswire

3 months ago

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

GlobeNewswire

3 months ago

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

GlobeNewswire

4 months ago

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

GlobeNewswire

5 months ago

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

GlobeNewswire

6 months ago

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

GlobeNewswire

6 months ago

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

GlobeNewswire

6 months ago

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection

GlobeNewswire

6 months ago

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement

GlobeNewswire

6 months ago

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

GlobeNewswire

8 months ago

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

GlobeNewswire

8 months ago

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

GlobeNewswire

8 months ago

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Celsius (NASDAQ:CELH): Strongest Q3 Results from the Beverages and Alcohol Group

StockStory

10 months ago

Celsius (NASDAQ:CELH): Strongest Q3 Results from the Beverages and Alcohol Group

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Simply Wall St.

10 months ago

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Zacks

10 months ago

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Tiptree Inc.'s (NASDAQ:TIPT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Simply Wall St.

10 months ago

Tiptree Inc.'s (NASDAQ:TIPT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

ZeroFox to Participate in 26th Annual Needham Growth Conference

GlobeNewswire

10 months ago

ZeroFox to Participate in 26th Annual Needham Growth Conference

Scholastic (NASDAQ:SCHL) Will Pay A Dividend Of $0.20

Simply Wall St.

10 months ago

Scholastic (NASDAQ:SCHL) Will Pay A Dividend Of $0.20

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

GlobeNewswire

a year ago

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

Relmada Therapeutics Provides Corporate Update

PR Newswire

a year ago

Relmada Therapeutics Provides Corporate Update

Ur-Energy Inc. (TSE:URE) most popular amongst individual investors who own 49% of the shares, institutions hold 40%

Simply Wall St.

a year ago

Ur-Energy Inc. (TSE:URE) most popular amongst individual investors who own 49% of the shares, institutions hold 40%

At US$20.32, Is It Time To Put Nu Skin Enterprises, Inc. (NYSE:NUS) On Your Watch List?

Simply Wall St.

a year ago

At US$20.32, Is It Time To Put Nu Skin Enterprises, Inc. (NYSE:NUS) On Your Watch List?

Why QuickLogic (QUIK) Dipped More Than Broader Market Today

Zacks

a year ago

Why QuickLogic (QUIK) Dipped More Than Broader Market Today

2024 election: $16B expected to be spent on political ads

Yahoo Finance Video

a year ago

2024 election: $16B expected to be spent on political ads

Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?

Alpha Teknova Insiders Land Bargain With Gains Of US$1.4m

Simply Wall St.

a year ago

Alpha Teknova Insiders Land Bargain With Gains Of US$1.4m

The Zacks Analyst Blog Highlights Enanta, OneConnect Financial, KNOT Offshore, Hippo Holdings and H World

Zacks

a year ago

The Zacks Analyst Blog Highlights Enanta, OneConnect Financial, KNOT Offshore, Hippo Holdings and H World

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

AMREP Corporation's (NYSE:AXR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

a year ago

AMREP Corporation's (NYSE:AXR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Pixelworks Empowers OnePlus 12 Smartphone to Deliver a Fully Immersive Gaming Experience

PR Newswire

a year ago

Pixelworks Empowers OnePlus 12 Smartphone to Deliver a Fully Immersive Gaming Experience

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Citi Trends, Inc. (NASDAQ:CTRN) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Citi Trends, Inc. (NASDAQ:CTRN) Q3 2023 Earnings Call Transcript

111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript

Sangoma Technologies Partnership Powers UK PSTN Switch-Off Opportunities

Business Wire

a year ago

Sangoma Technologies Partnership Powers UK PSTN Switch-Off Opportunities

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

GlobeNewswire

a year ago

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

Tata Advanced Systems and Satellogic Sign Strategic Contract to Build LEO Satellites in India

Business Wire

a year ago

Tata Advanced Systems and Satellogic Sign Strategic Contract to Build LEO Satellites in India

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

GlobeNewswire

a year ago

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

Aemetis, Inc. (NASDAQ:AMTX) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Aemetis, Inc. (NASDAQ:AMTX) Q3 2023 Earnings Call Transcript

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE

CNW Group

a year ago

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE

Ecofin Sustainable and Social Impact Term Fund (TEAF) Announces its Upcoming Monthly Distributions

ACCESSWIRE

a year ago

Ecofin Sustainable and Social Impact Term Fund (TEAF) Announces its Upcoming Monthly Distributions

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

GlobeNewswire

a year ago

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

Largo Reports Third Quarter 2023 Financial Results; Announces First Commercial Shipment of Ilmenite as By-Product of its Vanadium Operations in Brazil and Validation of its 6 MWh Vanadium Redox Flow Battery to Operate on Test Conditions in Spain

Business Wire

a year ago

Largo Reports Third Quarter 2023 Financial Results; Announces First Commercial Shipment of Ilmenite as By-Product of its Vanadium Operations in Brazil and Validation of its 6 MWh Vanadium Redox Flow Battery to Operate on Test Conditions in Spain

Associated Press Finance

a year ago

Assembly Biosciences: Q3 Earnings Snapshot

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

GlobeNewswire

a year ago

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates

GlobeNewswire

a year ago

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates

Allot (NASDAQ:ALLT shareholders incur further losses as stock declines 14% this week, taking three-year losses to 84%

Simply Wall St.

a year ago

Allot (NASDAQ:ALLT shareholders incur further losses as stock declines 14% this week, taking three-year losses to 84%

Sonida Senior Living Names Tabitha Obenour Chief Clinical Officer

Business Wire

a year ago

Sonida Senior Living Names Tabitha Obenour Chief Clinical Officer

Network-1 Reports Third Quarter Results

ACCESSWIRE

a year ago

Network-1 Reports Third Quarter Results

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

GlobeNewswire

a year ago

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Share on Social Networks: